Ethics and patentability in biotechnology.
نویسنده
چکیده
The systems of patent rights in force in Europe today, both at the level of national law and on the regional level, contain general clauses prohibiting the patenting of inventions whose publication and exploitation would be contrary to "ordre public" or morality. Recent years have brought frequent discussion about limiting the possibility of patent protection for biotechnological inventions for ethical reasons. This is undoubtedly a result of the dynamic development in this field in the last several years. Human genome sequencing, the first successful cloning of mammals, and the progress in human stem cell research present humanity with many new questions of an ethical nature. Directive 98/44 of the European Parliament and of the Council of July 6, 1998, on the Legal Protection of Biotechnological Inventions created a new basis for patent protection in this field of technology. Based on the European experience to now, however, it must be said that patent law is not the right place to legislate the consequences of the morality of an invention.
منابع مشابه
چالش‌های اخلاقی حمایت از روش‌های علم پزشکی در حقوق اختراعات
Human inventions and innovations are generally subject to legal protection but some of these innovations are not subject to legal protection. Medical methods are one of the controversial exceptions of patentability of inventions and opponents and proponents of patent ability of medical methods support propound several reasons to prove their theory. While major arguments of proponents are justif...
متن کاملDisease genes are not patentable: a rebuttal of McGee.
Dr. McGee presents a cogent argument for the patentability of the diagnosis of gene forms that are found to be associated with disease or other phenotypic manifestations. We’re convinced he’s wrong. An analogy will help explain why.
متن کاملBetween Scylla and Charybdis: Patentability and Morality Related to Human Embryonic Stem Cells
The patentability of inventions related to Human Embryonic Stem Cells (HESC) is challenged by the morality provision of various nations’ regulations. 1 This Article discusses whether it is a matter of expediency to prohibit granting patents to HESC-related inventions based on moralitybased provisions, and it concludes that this is not appropriate. To claim this, the Article explores typical cas...
متن کاملComparative Study of Patentability of Drug Polymorphism in Iran and the USA
Drug polymorphs are defined as a different arrangement of the same active compounds in crystalline form, which can potentially affect its therapeutic activity by changing the dissolution profile of drug upon administration. Discovery of new polymorphs therefore can provide added value for a previously marketed drug, due to the new advantages provided by the novel polymorph. Therefore, there is ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Science and engineering ethics
دوره 11 1 شماره
صفحات -
تاریخ انتشار 2005